Tag:
vaccines
Latest Headlines
Latest Headlines
New research shows how deadly H7N9 bird flu mutates, spreads
As the H7N9 avian influenza outbreak in China grows, global leaders are becoming increasing concerned that the deadly flu virus could mutate into a pandemic.
GSK monitored parents' online vaccination discussions for 2 months
GlaxoSmithKline has been listening to parents' concerns about childhood vaccinations. Really listening. In fact, it has used big data analytics to sift through thousands of comments from Internet chat forums to try to get a better grasp of exactly what objections there are and how to best face them.
Negative vaccine views spread like viruses on Twitter
The rise of the Internet--and social networks in particular--has provided a way of tracking the spread of ideas, the way an epidemiologist follows a virus. Now researchers have used this analytical approach to track the viral spread of opinions about vaccines.
Can public health campaigns goose Gardasil and Cervarix sales?
Public health experts are worried about the latest numbers on HPV vaccine uptake. After all, the shots can prevent cervical cancer, and that's no small thing. so, with a majority of girls eschewing the shots, government officials and others are trying to figure out how to turn the tide.
Computer game rewards players for shirking flu shots
Flu shots help stem the spread of flu, yet many millions of Americans don't get them. Economists have puzzled over the issue and came up with some interesting conclusions from their use of a computer game to study human behaviors related to protecting against disease.
WHO clearance to hoist Indian vaccine exports
The growing market received a major boost this week with an announcement from the World Health Organization that the country's national regulatory authority and affiliated institutions meet the prescribed international standards to supply vaccines to international bodies such as the WHO, UNICEF and the World Bank.
Can Dynavax overcome Heplisav blow?
Two weeks ago, an FDA panel dealt a blow to Dynavax Technologies, raising concerns about the safety of the company's hepatitis B vaccine, Heplisav. Shares dropped and investors tend to turn their backs on a company when stock prices go down. But is the company's future really all that grim?
In search of a lasting flu vaccine
Every flu season, doctors and pharmacists must stock up on the latest influenza vaccine to offer patients. Unlike other vaccines that provide decades worth of protection, the flu vaccine needs to be administered every year. But researchers are looking to change this.
Italy bans Novartis influenza vaccines
Italy banned the sale of Novartis influenza vaccines pending tests for possible side effects, and Switzerland took precautions too, Reuters reports. Initial reports show the ban followed discovery of white particles in the injections.
Transplant anti-rejection treatment could be next cancer drug
Rapamycin--long used as an anti-rejection drug for transplant patients--will be tested against a number of cancers in a new preliminary study.
